Boiron USA (BOI) Stock Price & News

Why is BOI up 3,41%?

Dive Deeper

BOI:EPA

Boiron USA

19,70 €

+3,41%

(+0,65) 1D

5 նոյ, 14:46:02 GMT+1 · EUR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for BOI...

Open

19,10 €

High

19,95 €

Low

19,10 €

Mkt. cap

345,64 մլն

Avg. vol.

5,00 հզր

Volume

1,93 հզր

P/E ratio

13,06

52-wk high

32,25 €

52-wk low

16,90 €

EPS

1,51 €

Shares outstanding

17,55 մլն

No. of employees

3 հզր

Open

19,10 €

High

19,95 €

Low

19,10 €

Mkt. cap

345,64 մլն

Avg. vol.

5,00 հզր

Volume

1,93 հզր

P/E ratio

13,06

52-wk high

32,25 €

52-wk low

16,90 €

EPS

1,51 €

Shares outstanding

17,55 մլն

No. of employees

3 հզր

Related stocks

Bank of East Asia Ltd

News stories

From web sources and news partners

www.marketscreener.com

27 րոպե առաջ

Primech Holdings (Nasdaq: PMEC) Secures Approximately US$1.67 Million in Cleaning Services Contracts Running to 2029 Across Singapore’s Industrial and Residential Sectors

FinancialContent

35 րոպե առաջ

CRA (NASDAQ:CRAI) reports strong Q3 2026, full-year sales guidance is optimistic

PR Newswire Canada

18 րոպե առաջ

NYSE Chair Sharon Bowen Earns Lifetime Achievement Award: NYSE Content Update

Yahoo Finance

19 րոպե առաջ

Nova (NASDAQ:NVMI) Q3: beats on revenue but stock drops

Profile

Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index. In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations. Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs". Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia

About Boiron USA

CEO-

Employees2,62 հզր

Founded07 հնս, 1932 թ.

Headquarters-

Sector-

Industry-

Websiteboiron.fr

All values in EUR	2025 թ. սեպ	2025 թ. դեկ	2026 թ. մրտ	2026 թ. հնս
Revenue	127,73 մլն	127,73 մլն	120,16 մլն	120,16 մլն
Cost of goods sold	35,40 մլն	35,40 մլն	33,53 մլն	33,53 մլն
Cost of revenue	35,40 մլն	35,40 մլն	33,53 մլն	33,53 մլն
Research and development expenses	1,56 մլն	1,56 մլն	1,44 մլն	1,44 մլն
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	79,26 մլն	79,26 մլն	79,95 մլն	79,95 մլն
Operating expense	77,52 մլն	77,52 մլն	81,88 մլն	81,88 մլն
Total operating expenses	112,92 մլն	112,92 մլն	115,41 մլն	115,41 մլն
Operating income	14,81 մլն	14,81 մլն	4,76 մլն	4,76 մլն
Other non operating income	-1,13 մլն	-1,13 մլն	-2,29 մլն	-2,29 մլն
EBT including unusual items	13,82 մլն	13,82 մլն	4,02 մլն	4,02 մլն
EBT excluding unusual items	13,16 մլն	13,16 մլն	2,75 մլն	2,75 մլն
Income tax expense	3,18 մլն	3,18 մլն	1,56 մլն	1,56 մլն
Effective tax rate	22,99%	22,99%	38,90%	38,90%
Other operating expenses	-3,30 մլն	-3,30 մլն	488,00 հզր	488,00 հզր
Net income	10,64 մլն	10,64 մլն	2,46 մլն	2,46 մլն
Net profit margin	8,33%	8,33%	2,04%	2,04%
Earnings per share	-	-	-	-
Interest and investment income	653,00 հզր	653,00 հզր	636,50 հզր	636,50 հզր
Interest expense	-335,00 հզր	-335,00 հզր	-410,00 հզր	-410,00 հզր
Net interest expenses	318,00 հզր	318,00 հզր	226,50 հզր	226,50 հզր
Depreciation and amortization charges	-	-	-	-
EBITDA	18,06 մլն	18,06 մլն	11,17 մլն	11,17 մլն
Gain or loss from assets sale	-446,00 հզր	-446,00 հզր	-	-

Ask anything